Innorna
Shanghai, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
An RNA therapeutics company developing novel LNP delivery systems for targeted genetic medicines and vaccines.
Genetics & GenomicsOncologyRare Diseases
Technology Platform
Proprietary LNP delivery platform featuring novel, designed ionizable lipids for targeted tissue delivery of various RNA therapeutics.
Opportunities
Addressing the major unmet need of extrahepatic delivery to unlock the full potential of RNA therapeutics for a wider range of diseases.
Risk Factors
High technical risk associated with novel delivery technology and intense competition from well-funded global players with established platforms.
Competitive Landscape
Competes in the crowded but innovative RNA delivery space, aiming to differentiate through its novel LNP formulations for hard-to-reach tissues.